These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 16608842)

  • 21. Reduced plasma membrane expression of dysferlin mutants is attributed to accelerated endocytosis via a syntaxin-4-associated pathway.
    Evesson FJ; Peat RA; Lek A; Brilot F; Lo HP; Dale RC; Parton RG; North KN; Cooper ST
    J Biol Chem; 2010 Sep; 285(37):28529-39. PubMed ID: 20595382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Normal myoblast fusion requires myoferlin.
    Doherty KR; Cave A; Davis DB; Delmonte AJ; Posey A; Earley JU; Hadhazy M; McNally EM
    Development; 2005 Dec; 132(24):5565-75. PubMed ID: 16280346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dysferlin regulates cell adhesion in human monocytes.
    de Morrée A; Flix B; Bagaric I; Wang J; van den Boogaard M; Grand Moursel L; Frants RR; Illa I; Gallardo E; Toes R; van der Maarel SM
    J Biol Chem; 2013 May; 288(20):14147-14157. PubMed ID: 23558685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dysferlin is a plasma membrane protein and is expressed early in human development.
    Anderson LV; Davison K; Moss JA; Young C; Cullen MJ; Walsh J; Johnson MA; Bashir R; Britton S; Keers S; Argov Z; Mahjneh I; Fougerousse F; Beckmann JS; Bushby KM
    Hum Mol Genet; 1999 May; 8(5):855-61. PubMed ID: 10196375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of myoferlin in skeletal muscles of patients with dysferlinopathy.
    Inoue M; Wakayama Y; Kojima H; Shibuya S; Jimi T; Oniki H; Nishino I; Nonaka I
    Tohoku J Exp Med; 2006 Jun; 209(2):109-16. PubMed ID: 16707852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Membrane repair defects in muscular dystrophy are linked to altered interaction between MG53, caveolin-3, and dysferlin.
    Cai C; Weisleder N; Ko JK; Komazaki S; Sunada Y; Nishi M; Takeshima H; Ma J
    J Biol Chem; 2009 Jun; 284(23):15894-902. PubMed ID: 19380584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abnormal expression of dysferlin in skeletal muscle and monocytes supports primary dysferlinopathy in patients with one mutated allele.
    Meznaric M; Gonzalez-Quereda L; Gallardo E; de Luna N; Gallano P; Fanin M; Angelini C; Peterlin B; Zidar J
    Eur J Neurol; 2011 Jul; 18(7):1021-3. PubMed ID: 21658164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of insulin-like growth factor II (IGF-II), IGF binding protein-2 and myogenin during differentiation of myogenic satellite cells derived from the turkey.
    Ernst CW; McFarland DC; White ME
    Differentiation; 1996 Oct; 61(1):25-33. PubMed ID: 8921582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Satellite cell proliferation and the expression of myogenin and desmin in regenerating skeletal muscle: evidence for two different populations of satellite cells.
    Rantanen J; Hurme T; Lukka R; Heino J; Kalimo H
    Lab Invest; 1995 Mar; 72(3):341-7. PubMed ID: 7898053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired muscle growth and response to insulin-like growth factor 1 in dysferlin-mediated muscular dystrophy.
    Demonbreun AR; Fahrenbach JP; Deveaux K; Earley JU; Pytel P; McNally EM
    Hum Mol Genet; 2011 Feb; 20(4):779-89. PubMed ID: 21127009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myogenin expression, cell cycle withdrawal, and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis.
    Andrés V; Walsh K
    J Cell Biol; 1996 Feb; 132(4):657-66. PubMed ID: 8647896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SV40 T antigen inhibits expression of MyoD and myogenin, up-regulates Myf-5, but does not affect early expression of desmin or alpha 7 integrin during muscle development.
    Haider SR; Wang W; Kaufman SJ
    Exp Cell Res; 1994 Feb; 210(2):278-86. PubMed ID: 7507852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Muscle inflammation and MHC class I up-regulation in muscular dystrophy with lack of dysferlin: an immunopathological study.
    Confalonieri P; Oliva L; Andreetta F; Lorenzoni R; Dassi P; Mariani E; Morandi L; Mora M; Cornelio F; Mantegazza R
    J Neuroimmunol; 2003 Sep; 142(1-2):130-6. PubMed ID: 14512171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of oxidative stress, nuclear factor kappa B and the ubiquitin proteasomal pathway in dysferlinopathy.
    Rajakumar D; Senguttuvan S; Alexander M; Oommen A
    Life Sci; 2014 Jul; 108(1):54-61. PubMed ID: 24846833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased susceptibility to complement attack due to down-regulation of decay-accelerating factor/CD55 in dysferlin-deficient muscular dystrophy.
    Wenzel K; Zabojszcza J; Carl M; Taubert S; Lass A; Harris CL; Ho M; Schulz H; Hummel O; Hubner N; Osterziel KJ; Spuler S
    J Immunol; 2005 Nov; 175(9):6219-25. PubMed ID: 16237120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dysferlin interacts with affixin (beta-parvin) at the sarcolemma.
    Matsuda C; Kameyama K; Tagawa K; Ogawa M; Suzuki A; Yamaji S; Okamoto H; Nishino I; Hayashi YK
    J Neuropathol Exp Neurol; 2005 Apr; 64(4):334-40. PubMed ID: 15835269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a regulatory function for an orphan receptor in muscle: COUP-TF II affects the expression of the myoD gene family during myogenesis.
    Muscat GE; Rea S; Downes M
    Nucleic Acids Res; 1995 Apr; 23(8):1311-8. PubMed ID: 7753622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dysferlin and myoferlin regulate transverse tubule formation and glycerol sensitivity.
    Demonbreun AR; Rossi AE; Alvarez MG; Swanson KE; Deveaux HK; Earley JU; Hadhazy M; Vohra R; Walter GA; Pytel P; McNally EM
    Am J Pathol; 2014 Jan; 184(1):248-59. PubMed ID: 24177035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SV40 large T antigen-induced inhibition of terminal differentiation of primary skeletal muscle cells is associated with a block in the expression of MyoD and myogenin.
    Van De Klundert FA; Bloemendal H
    Mol Biol Rep; 1994-1995; 20(3):143-8. PubMed ID: 7565654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 6th Dysferlin Conference, 3-6 April 2013, Arlington, Virginia, USA.
    Albrecht DE; Rufibach LE; Williams BA; Lee ER; Windish HP; Hwang EY; Shira SR; Mittal P
    Neuromuscul Disord; 2014 Mar; 24(3):277-87. PubMed ID: 24480524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.